Free Weekly Newsletter.
We've been publishing our newsletter since 1998, and have had our share of huge winners including Immunomedics (IMMU) $3.00 to $86.00 (2016-2020). So sign up, it's free, and see what else we can come up with!
ALL NEWS
Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.
If you're familiar with the term, "..the stars are aligning" here is a real life example. If you're familiar with the term, "..wind at their back" the winds are building heavily right...
Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.
Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion) and there are so few shares outstanding, it is in...
Three That Doubled, Three More That May Double.
Ardelyx $3.00 (ARDX) Gains 117%, Provention Bio $8.75 (PRVB) Gains 134%, and PharmaTher (PHRRF) up 154%. Blue Skies Ahead - For All Three.
Revive Therapeutics $0.10 (RVVTF), Silo Pharma...
Society Pass (SOPA) Research Reports
RESEARCH REPORTS
Institutional Analyst Inc.
Subscribe to receive next report on Society Pass.
Adding Society Pass (SOPA) $0.96 to the Watch List
Amazing Fast Grower, in the Asian Silicon Valley.
After a wildly successful IPO debut and subsequent tumble, Society Pass (SOPA) in our opinion is attractive on both a...
PNF Accountants & Advisors Cocktail Hour!
Thursday, 6:00 PM at Hagerty Garage & Social
Tonya Notaro
Hagerty Garage & Social along with PNF Accountants & Advisors invites...
Ouch, for Now. Progressive Care Does 200:1 Reverse.
MASSIVE REVERSE SPLIT
Let's just watch from the sidelines for now. If you had 100,000 shares last Friday, you now...
Silo Pharma (SILO) Trades up 90% Friday, With 23 Million Shares Traded!
And We Weren't Watching!
It was Friday after all, and the last day of the year, and we were celebrating our 78% gain in Ardelyx (ARDX). So we didn't...
Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE...
Carbon Credit Charts.
Carbon Streaming Corp. (OFSTF)
Base Carbon Inc. (BCBNF)
Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.
The Higher it Goes, The More Nervous we Get.
LIVE QUOTE
Not much...
Smart for Life (SMFL) Announces Launch of Greens First Protein Bars.
New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super Foods, Expected Launch in Q1 2023
MIAMI,...
FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.
Oh boy, another day, another snag. There goes our Christmas bonus, dang.
LIVE QUOTE
It's been a gut wrenching couple years for shareholders. Is it big...
Scalpers Get Scalped!
Go Big or go Home. SEC Charges Eight Social Media Influencers in $100 Million Profit Stock Scheme.
SEC Charges Eight Social Media Influencers in $100 Million Stock Manipulation...
Adding Unicycive (UNCY) $0.75 to the Watch List.
Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is a biotech in the business of developing Renazorb.
Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.
If you're familiar with the term, "..the stars are aligning" here is a real life example. If you're familiar with the term, "..wind at their back" the winds are building heavily right...
Initiating Coverage on Society Pass (SOPA).
Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
NEW YORK, NY, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Institutional Analyst...
Society Pass (SOPA) Research Reports
RESEARCH REPORTS
Institutional Analyst Inc.
Subscribe to receive next report on Society Pass.
Adding Society Pass (SOPA) $0.96 to the Watch List
Amazing Fast Grower, in the Asian Silicon Valley.
After a wildly successful IPO debut and subsequent tumble, Society Pass (SOPA) in our opinion is attractive on both a...
Smart for Life (SMFL) Announces Launch of Greens First Protein Bars.
New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super Foods, Expected Launch in Q1 2023
MIAMI,...
Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.
Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...
ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA, yet the Psychedelic Sector...
Both a bad day and a Good day for Psychedelics.
Atai was founded in 2018 and went public in...
Ouch, for Now. Progressive Care Does 200:1 Reverse.
MASSIVE REVERSE SPLIT
Let's just watch from the sidelines for...
He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!
Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along.
Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
IPOS
New Preferred Stock IPOs, October 2019
Article ArchivePreferred Stock Investing Website
Summary
Thirteen new preferred stocks were introduced during October offering...
conference calls
Peloton Plunges $9 Billion in Value, on a $805 Million Quarter!
Peloton just reported the $805 million for three months worth of business ended September. That's $9 million worth of fitness everyday. And...
Most popular
Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...
New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.
Citius (CTXR) CEO Myron Holubiak Live on TV, 1:20 Today, June 30th.
VIDEO: Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
Draganfly (DFLYF)Announces Record Revenues & Shareholder Call.
LIVE QUOTE
Vancouver, BC, May 27, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB:...